Organization
Infiniti is a global animal health technology company with direct sales to more than 30 countries worldwide. We have assembled a best-in-class team of clinicians, engineers, designers, programmers, and support staff that develops and curates meaningful and impactful solutions. Our promise is to enrich animal health and create a brighter future with global impact.
One company, many pathways
In answering the needs of clinicians, Infiniti has found synergistic opportunities in many clinical areas. This led to the creation of neuromed in 2020 and the acquisition of Orthomed in 2019. Infiniti continuously searches for new opportunities in adjacent areas within animal health.
Orthopedic issues constitute some of the most frequent conditions afflicting pets. Orthomed has developed a number of proprietary orthopedic solutions and has a rich tradition of innovation. Landmark developments include SOPTM, RidgestopTM, and MMP. Orthomed has a number of innovative solutions in development and provides support and education for a wide range of orthopedic conditions.
In 2020, Infiniti created neuromed, a company focused on neurologic disease in companion animals. Regarded by many as an orphaned area of innovation, neuromed has leveraged Infiniti’s innovation ethos to develop a portfolio of novel solutions that address common issues involving the central and peripheral nervous systems.